BioCentury
ARTICLE | Company News

BioRelix, Dalton Chemical Laboratories Inc. deal

November 19, 2007 8:00 AM UTC

Dalton will design and synthesize compounds against undisclosed RiboSwitch bacterial RNA targets from BioRelix. BioRelix will further develop the compounds as anti-infectives. RiboSwitches are short s...